The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CELESTIMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab plus lenalidomide versus rituximab plus lenalidomide in patients with relapsed or refractory follicular lymphoma who have received ≥ 1 line of systemic therapy.
 
Loretta J. Nastoupil
Honoraria - ADC Therapeutics; Bayer; Bristol-Myers Squibb; Celgene; Epizyme; Genmab; Gilead Sciences; Janssen Oncology; Morphosys; Novartis; Pfizer; Takeda; TG Therapeutics
Research Funding - Allogene Therapeutics; Caribou Biosciences; Celgene; Epizyme; Genentech/Roche; Gilead Sciences; IgM Biosciences; Janssen Biotech; Novartis; Takeda; TG Therapeutics
 
Franck Morschhauser
Honoraria - Chugai/Roche; Eisai; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; epizyme; Genmab; Gilead Sciences; Novartis; Roche/Genentech; SERVIER
Expert Testimony - Roche/Genentech
 
Christian W. Scholz
Honoraria - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Incyte; Janssen Oncology; Lilly; MSD Oncology; Novartis; Roche; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Daiichi Sankyo Europe GmbH; Gilead Sciences; Hexal; Janssen; Merck Serono; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Janssen; Roche
 
Mark Bishton
Honoraria - Teva
Consulting or Advisory Role - Incyte; Roche
Travel, Accommodations, Expenses - Takeda
 
Sung-Soo Yoon
Honoraria - Novartis
Consulting or Advisory Role - Amgen; Celgene/Jazz; Janssen; Takeda
Research Funding - Kyowa Kirin; Roche/Genentech; Yuhan
 
Pratyush Giri
No Relationships to Disclose
 
Michael C. Wei
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Andrea Knapp
Employment - Roche
 
Chi-Chung Li
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Patents, Royalties, Other Intellectual Property - patent applications pertaining to the development and dosing of bispecific antibodies
 
Alessia Bottos
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Haocheng Li
Employment - Roche Canada
 
Enkhtsetseg Purev
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Nancy L. Bartlett
Consulting or Advisory Role - Acerta Pharma; ADC Therapeutics; BTG; Roche/Genentech; Seagen
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)